01
Utility before novelty
Define the decision a genomic service improves and the evidence needed to justify its use.
Expertise / Genomics & precision prevention
Genomics and Precision-Prevention Strategy
Translating genomic evidence into responsible services with clear utility, understandable choices, and reliable operating pathways.
The strategic question
How should genomic insight become a trusted, clinically responsible service?
A useful answer must connect evidence, population need, service design, governance, implementation, and measurement. Isolating any one of these creates avoidable risk elsewhere in the system.
The objective is not a universal blueprint. It is a defensible set of choices suited to the organization’s mandate, maturity, capabilities, and context.
Working principles
02
Trust by design
Build consent, privacy, uncertainty communication, counseling, and appropriate choice into the pathway.
03
End-to-end quality
Treat acquisition, collection, laboratories, interpretation, delivery, referral, and follow-up as one system.
Decisions this perspective supports
01Which use cases have sufficient utility
02How consent and uncertainty are communicated
03What clinical and laboratory governance is required
04How access, quality, and economics remain sustainable